Thrombotic disorders

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Thromboembolism occurs as a consequence of the genetic predisposition, underlying diseases, and triggers of dehydration, infection, and injury. Thrombotic events are much rarer in infants and children than in adults. Aging is a potent risk factor for the development of venous thrombosis and stroke. The genetic effects on the hypercoagulability in pediatric patients are thus more carefully considered than in adult patients. The genetic predisposition of thromboembolism depends on the racial background. Factor V Leiden (G1691A) and factor II variant (G20210A) are the common thrombophilias in Caucasians, but not found in Asian ancestries. The incidence of pediatric thrombosis is increasing because of the advances in neonatal intensive care, cardiovascular surgery, and imaging techniques. There is an increasing number of reports on the molecular epidemiology of constitutional thrombophilias also in Asian countries. On the other hand, the treatment and prophylaxis of pediatric thrombosis have not been established. The advent of direct oral anticoagulants (DOACs) has opened a new era of anticoagulation for adult patients with thrombosis, while the management of heritable thrombophilia is under investigation. This chapter briefly introduces the thrombotic disorders in neonates, infants, and children, with special reference to the high-risk-inherited thrombophilia of natural anticoagulant deficiency.

Original languageEnglish
Title of host publicationHematological Disorders in Children
Subtitle of host publicationPathogenesis and Treatment
PublisherSpringer Singapore
Pages205-221
Number of pages17
ISBN (Electronic)9789811038860
ISBN (Print)9789811038853
DOIs
Publication statusPublished - Jun 14 2017

Fingerprint

Thrombophilia
Thrombosis
Thromboembolism
Genetic Predisposition to Disease
Pediatrics
Anticoagulants
Neonatal Intensive Care
Molecular Epidemiology
Dehydration
Venous Thrombosis
Stroke
Newborn Infant
Incidence
Wounds and Injuries
Infection
factor V Leiden
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Ohga, S., & Ishimura, M. (2017). Thrombotic disorders. In Hematological Disorders in Children: Pathogenesis and Treatment (pp. 205-221). Springer Singapore. https://doi.org/10.1007/978-981-10-3886-0_10

Thrombotic disorders. / Ohga, Shouichi; Ishimura, Masataka.

Hematological Disorders in Children: Pathogenesis and Treatment. Springer Singapore, 2017. p. 205-221.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ohga, S & Ishimura, M 2017, Thrombotic disorders. in Hematological Disorders in Children: Pathogenesis and Treatment. Springer Singapore, pp. 205-221. https://doi.org/10.1007/978-981-10-3886-0_10
Ohga S, Ishimura M. Thrombotic disorders. In Hematological Disorders in Children: Pathogenesis and Treatment. Springer Singapore. 2017. p. 205-221 https://doi.org/10.1007/978-981-10-3886-0_10
Ohga, Shouichi ; Ishimura, Masataka. / Thrombotic disorders. Hematological Disorders in Children: Pathogenesis and Treatment. Springer Singapore, 2017. pp. 205-221
@inbook{bd42d823c78142029094fb795f250156,
title = "Thrombotic disorders",
abstract = "Thromboembolism occurs as a consequence of the genetic predisposition, underlying diseases, and triggers of dehydration, infection, and injury. Thrombotic events are much rarer in infants and children than in adults. Aging is a potent risk factor for the development of venous thrombosis and stroke. The genetic effects on the hypercoagulability in pediatric patients are thus more carefully considered than in adult patients. The genetic predisposition of thromboembolism depends on the racial background. Factor V Leiden (G1691A) and factor II variant (G20210A) are the common thrombophilias in Caucasians, but not found in Asian ancestries. The incidence of pediatric thrombosis is increasing because of the advances in neonatal intensive care, cardiovascular surgery, and imaging techniques. There is an increasing number of reports on the molecular epidemiology of constitutional thrombophilias also in Asian countries. On the other hand, the treatment and prophylaxis of pediatric thrombosis have not been established. The advent of direct oral anticoagulants (DOACs) has opened a new era of anticoagulation for adult patients with thrombosis, while the management of heritable thrombophilia is under investigation. This chapter briefly introduces the thrombotic disorders in neonates, infants, and children, with special reference to the high-risk-inherited thrombophilia of natural anticoagulant deficiency.",
author = "Shouichi Ohga and Masataka Ishimura",
year = "2017",
month = "6",
day = "14",
doi = "10.1007/978-981-10-3886-0_10",
language = "English",
isbn = "9789811038853",
pages = "205--221",
booktitle = "Hematological Disorders in Children",
publisher = "Springer Singapore",

}

TY - CHAP

T1 - Thrombotic disorders

AU - Ohga, Shouichi

AU - Ishimura, Masataka

PY - 2017/6/14

Y1 - 2017/6/14

N2 - Thromboembolism occurs as a consequence of the genetic predisposition, underlying diseases, and triggers of dehydration, infection, and injury. Thrombotic events are much rarer in infants and children than in adults. Aging is a potent risk factor for the development of venous thrombosis and stroke. The genetic effects on the hypercoagulability in pediatric patients are thus more carefully considered than in adult patients. The genetic predisposition of thromboembolism depends on the racial background. Factor V Leiden (G1691A) and factor II variant (G20210A) are the common thrombophilias in Caucasians, but not found in Asian ancestries. The incidence of pediatric thrombosis is increasing because of the advances in neonatal intensive care, cardiovascular surgery, and imaging techniques. There is an increasing number of reports on the molecular epidemiology of constitutional thrombophilias also in Asian countries. On the other hand, the treatment and prophylaxis of pediatric thrombosis have not been established. The advent of direct oral anticoagulants (DOACs) has opened a new era of anticoagulation for adult patients with thrombosis, while the management of heritable thrombophilia is under investigation. This chapter briefly introduces the thrombotic disorders in neonates, infants, and children, with special reference to the high-risk-inherited thrombophilia of natural anticoagulant deficiency.

AB - Thromboembolism occurs as a consequence of the genetic predisposition, underlying diseases, and triggers of dehydration, infection, and injury. Thrombotic events are much rarer in infants and children than in adults. Aging is a potent risk factor for the development of venous thrombosis and stroke. The genetic effects on the hypercoagulability in pediatric patients are thus more carefully considered than in adult patients. The genetic predisposition of thromboembolism depends on the racial background. Factor V Leiden (G1691A) and factor II variant (G20210A) are the common thrombophilias in Caucasians, but not found in Asian ancestries. The incidence of pediatric thrombosis is increasing because of the advances in neonatal intensive care, cardiovascular surgery, and imaging techniques. There is an increasing number of reports on the molecular epidemiology of constitutional thrombophilias also in Asian countries. On the other hand, the treatment and prophylaxis of pediatric thrombosis have not been established. The advent of direct oral anticoagulants (DOACs) has opened a new era of anticoagulation for adult patients with thrombosis, while the management of heritable thrombophilia is under investigation. This chapter briefly introduces the thrombotic disorders in neonates, infants, and children, with special reference to the high-risk-inherited thrombophilia of natural anticoagulant deficiency.

UR - http://www.scopus.com/inward/record.url?scp=85033193539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033193539&partnerID=8YFLogxK

U2 - 10.1007/978-981-10-3886-0_10

DO - 10.1007/978-981-10-3886-0_10

M3 - Chapter

AN - SCOPUS:85033193539

SN - 9789811038853

SP - 205

EP - 221

BT - Hematological Disorders in Children

PB - Springer Singapore

ER -